These findings imply that NK357 and NK391can alleviate oral pathogen-induced periodontitis, colitis, and CI by inducing NF-κB-involved BDNF and NMDAR expression through the regulation of gut microbiota and their byproducts. Here, NFKB1 is linked to periodontitis.